comparemela.com

Latest Breaking News On - Evgen sulforadex - Page 2 : comparemela.com

STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indications

/PRNewswire/ STALICLA SA, a precision neuroscience clinical stage biotech, advancing the first precision medicine platform (DEPI) for patients with.

Alderley parkBorough of cheshire eastUnited kingdomHuw jonesLynn durhamEvgen sulforadexEvgen pharmaJuvenescence ltdAutism spectrumNeurodevelopmental disordersAutism spectrum disorderOrphan drugLondon stock exchange

Investegate |Evgen Pharma PLC Announcements | Evgen Pharma PLC: SFX-01 licensing deal for up to $160 5m

Investegate announcements from Evgen Pharma PLC, SFX-01 licensing deal for up to $160.5m

Alderley parkBorough of cheshire eastUnited kingdomEvgen sulforadexEvgen pharmaplcNigel birks harrietHelen kuhlmanHuw jonesEvgen pharmaRichard moulsonGeoff nash teddy whileyJuvenescence ltdRegulatory information serviceInvestor meet companyCentral nervous systemMarket abuse regulations

Investegate |Evgen Pharma PLC Announcements | Evgen Pharma PLC: Regulatory approval for healthy volunteer study

Investegate announcements from Evgen Pharma PLC, Regulatory approval for healthy volunteer study

Alderley parkBorough of cheshire eastUnited kingdomHuw jonesEvgen sulforadexEvgen pharmaplcEvgen pharmaGeoff nash teddy whileyRichard moulsonJuvenescence ltdNominated advisorTeddy whileyCorporate financeNigel birksRozi morrisAgnes stephens

vimarsana © 2020. All Rights Reserved.